AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Axogen, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$35.24+0.62 (+1.79%)
Close on Oct 19, 2026
- Market cap
- $1.88B
- P/E (TTM)
- –
- Dividend yield
- –
Axogen, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q2 25 | Q1 25 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| United States | $69.01M | $60.13M | $55.85M | $47.84M | 99.0% | +23.6% |
| International | $726.00K | $1.33M | $815.00K | $717.00K | 1.0% | -10.9% |
From the segment and revenue-disaggregation notes of Axogen's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.